Besides, ERBB2 is likely to correlate with HER2-enriched and luminal B subtypes, since the results in [37] show that HER2-enriched (ER-negative) cases and luminal (ER-positive) cases both belongs to ERBB2-amplified cancer. The gene discussed is ERBB2; the disease is cancer.